| Charles N Roberts, MD | |
|
5633 N. Lidergerwood, Spokane, WA 99208 | |
| (509) 482-0111 | |
| Not Available |
| Full Name | Charles N Roberts |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 5633 N. Lidergerwood, Spokane, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104962356 | NPI | - | NPPES |
| 9611674 | Medicaid | WA | |
| MD00036933 | Other | WA | LICENCE |
| 8240764 | Medicaid | WA | |
| GAB10984 | Other | WA | MDC PIN # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00036933 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles N Roberts, MD 910 N Washington St, Suite 209, Spokane, WA 99201-2202 Ph: () - | Charles N Roberts, MD 5633 N. Lidergerwood, Spokane, WA 99208 Ph: (509) 482-0111 |
News Archive
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.
A provocative paper from Duke-NUS Medical School, published in the Journal of Experimental Medicine in March 2020, discusses the possibilities of creating new receptors on a sick person's own immune cells as a means of controlling the infection. This therapy is already being used to treat certain cancers with marked success.
Clyde Boyce has been hospitalized 14 times in the past four years. Boyce, 61, survived two strokes and five operations to unblock arteries around his heart, including three procedures in which doctors propped open his blood vessels with stents. He takes 18 pills a day and gets injections every two weeks with a powerful drug to lower cholesterol.
Human stem cells have been regarded as one of the promising cell sources for cardiac regeneration therapy.
Researchers in India have conducted a meta-analysis investigating the effects of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes among patients with COVID-19.
› Verified 6 days ago
Dr. Richard W Walker, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5633 N Lidgerwood St, Spokane, WA 99208 Phone: 509-484-8069 Fax: 509-462-4086 | |
Lynn Bergman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5633 N Lidgerwood, Emergency Physicians Services, Spokane, WA 99208 Phone: 509-482-2448 Fax: 509-482-2452 | |
Mary Anna Chiu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5633 N Lidgerwood St, Spokane, WA 99208 Phone: 509-482-2448 Fax: 509-482-2452 | |
David S Mcclellan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 | |
Stephen Penaskovic, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 | |
Michael J Wymore, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 |